ranolazinum 750 mg, cellulosum microcristallinum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, hypromellosum, magnesii stearas, natrii hydroxidum corresp. natrium 2.29 mg, Überzug: triacetinum, hypromellosum, lactosum monohydricum 12 mg, cera carnauba, E 171, E 102 40 µg, E 133, pro compresso obducto.
Packungsbestandteile
Delayed release tablets
Active Agent
Dose
Ranolazinum
750 mg
BAG: Active Agent
Dose
Ranolazinum
750 mg
Inactive agents
Dose
additional_information
Acidi Methacrylici
Cellulosum Microcristallinum
Cera Carnauba
E 102
40 µg
color.
E 133
color.
E 171
color.
Hypromellosum
Lactose Monohydrate
12 mg
Magnesii Stearas
Methylis Methacrylatis Polymerisatum
Sodium Hydroxide
Pro Compresso Obducto
Triacetinum
Überzug
Source
Data was imported : 04.12.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
